CVRx has raised $46.5 million a little more than 6 months after it received Expedited Access Pathway Designation from the FDA for its heart failure neuromodulation implant tech. The designation was gained because its Barostim Therapy is intended to treat heart failure patients who have no other treatment alternative.
Healthcare growth investor Essex Woodlands has backed Suneva Medical with a new $25 million financing aimed at expanding its marketing of the only FDA-approved dermal filler that's specifically indicated for smile lines or facial acne scars.
Intarcia is looking to boost its employee count to 400 by the end of this year, and to 800 in 2017 as it preps to move into a new 47,000-square-foot headquarters next month, the Boston Business Journal reported. It currently has 70 employees at its Boston location, with more than 200 total.
Medtronic is picking up a whole line of chronic disease management programs to market from a new partnership with Canary Health. The devices giant anticipates that the programs, which encourage and direct patients toward better self-care, will be reimbursable--which can be a tough hurdle for software-based approaches to disease.
Israeli startup BlueWind Medical has won a CE mark for its miniature wireless neurostimulation device to treat overactive bladder. The first-of-its-kind device is inserted using a minimally invasive procedure and could help improve the quality of life for patients with overactive bladder.
The FDA has added a fourth kind of obesity treatment device to its roster of approved interventions. The agency has approved the AspireAssist System from Pennsylvania-based startup Aspire Bariatrics. The device works to drain part of the stomach contents after each meal via a surgically place tube.
Intuitive Surgical is aiming to provide surgeons with more patient-specific information for use with its da Vinci Surgical System with its latest partnership. It's made a deal with telehealth provider InTouch Health to develop products to deliver 3-D reconstructions of anatomical structures for surgeons.
President Obama has previously listed organ transplantation among his top priorities for scientific advancement in the U.S. Now, the White House is releasing a detailed roster of its actions to support organ donation--and the technology that enables it--at an Organ Summit it's holding June 14.
Redwood City, CA-based Genomic Health launched its first liquid biopsy test Tuesday. The blood-based mutation test is intended to help physicians make treatment decisions regarding various stage IV solid cancers, including melanoma, breast, lung, ovarian and gastrointestinal stromal tumors.
Boston Scientific has received positive guidance from the National Institute for Health and Care Excellence (NICE) in support of the use of its GreenLight XPS Laser Therapy System to treat an enlarged prostate. The agency estimated that use of the system could save the U.K.'s National Health Service (NHS) up to £3.2 million annually by enabling an outpatient procedure for benign prostatic hyperplasia (BPH) rather than the traditional surgical resection.
Terumo will acquire Sequent Medical, which is working on a minimally invasive device to treat intracranial aneurysms. The Japanese devicemaker will pay $280 million up front for the Aliso Viejo, CA-based startup, with an additional $100 million to follow if development or commercial milestones are achieved.
Med tech companies have found only one reliable way to boost sales--that's to buy them. The only players with sizable sales increases last year were driven by major acquisitions, according to data from Evaluate Medtech.
When Apple started working on a smartwatch, it envisioned a device that could monitor blood pressure, heart rate and stress levels, but those functions turned out to be too complex. Now, as the company launches the third iteration of its smartwatch operating system, it's still looking at medical applications, but ones that don't land the device under unwanted regulator oversight.
A study from Kaiser Permanente found that remote monitoring and automated coaching using ResMed can "significantly improve" continuous positive airway pressure therapy compliance for patients suffering from obstructive sleep apnea.
Zimmer Biomet disclosed in an SEC filing that it has acquired Compression Therapy Concepts for an undisclosed sum.
Medtronic reported pivotal data for its hybrid closed-loop system at the American Diabetes Association conference in New Orleans, LA, over the weekend. The data show that the hybrid closed-loop system helped to decrease A1c levels as well as reduce variability in sensor glucose values for 124 patients with Type 1 diabetes.
In its second precision medicine tie-up this month, Thermo Fisher will collaborate with the West China Hospital of Sichuan University on a platform to research precision medicine.
WellDoc has released results from a study that aimed to evaluate the "feasibility and reach" of using a lay coach along with the BlueStar mobile app for those with Type 2 diabetes. The study found a large percentage of participants were engaged with the app, and many sent data generated from the app to their care team.
Johnson & Johnson has been sitting on its OneTouch Via patch-based insulin delivery system for a while now, and the tech is finally being launched. It is slated to debut the patch in limited ex-U.S. markets before year end, with a U.S. launch planned for "shortly thereafter," the company said.